Latest hepatitis C virus (HCV) reports, slide sets and infographics for England and the UK (Public Health England)
Bibliography: All Publications
EU Action Plan on Drugs 2017-2020
The Plan sets out the Actions that will be implemented to achieve the objectives of the Strategy (EUR-Lex)
Drug misuse: findings from the 2016 to 2017 CSEW
Examines the extent and trends in illicit drug use among a sample of 16 to 59 year old residents in households in England and Wales (Home Office)
Better care for people with co-occurring mental health and alcohol/drug use conditions (PDF)
A guide for commissioners and service providers (Public Health England)
More Australians dying of accidental overdose of pharmaceutical opioids
The report analyses cause of death data from the Australian Bureau of Statistics and found that in 2013, the last year for which finalised data is available, just under 600 (597) Australians between the ages of 15 and 54 died from accidental overdose of opioids with the majority 70 per cent being due to opioids other than heroin, including strong prescription painkillers (NDARC)
EMCDDA–Europol 2016 Annual Report on the implementation of Council Decision 2005/387/JHA
This report presents the key activities performed by the EMCDDA and Europol in 2016 and the results of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances, including new psychoactive substances notified in 2016 (EMCDDA)
Financial case for action on liver disease (PDF)
Escalating costs of alcohol misuse, obesity and viral hepatitis (Foundation for Liver Research)
Australian National Drug Strategy 2017-2026
For the first time, Australia has a long-term framework for reducing and preventing the harms associated with alcohol and other drugs through the agreement of a ten-year National Drug Strategy. This is a national strategic framework built on the principles of partnerships, coordination and collaboration, national direction and jurisdictional implementation, and evidence-informed response (Australian Government)
Crime in England and Wales: year ending March 2017
Includes a section o drugs (Office of National Statistics)
Canada’s Drug Futures Forum (PDF)
Summary of Proceedings and Final Recommendations (CDFF-FADE)
2017 Drug Strategy (PDF)
This Strategy sets out clear expectations for action from a wide range of partners, including those in education, health, safeguarding, criminal justice, housing and employment (HM Government, UK)
Drug misuse and dependence: UK guidelines on clinical management
Often called the Orange Book, this is guidance for clinicians treating people with drug problems (DoH, UK)
EMCDDA Budget 2017
The EMCDDA receives stable funding under Commission budget line B3-441 of the general budget of the European Union. Each year, a preliminary draft budget is presented by the Centre’s Director to the Management Board, which may modify the draft before adopting it and submitting it to the European Commission. The Commission, in turn, makes its recommendations (which may again alter the draft) and presents the result to the European Council and Parliament
Drug-related intimidation – The Irish situation and international responses: an evidence review (PDF)
This report presents the findings of an evidence review on drug-related intimidation (DRI) requested by the Department of Health on behalf of the Local and Regional Drugs and Alcohol Task Forces (HRB)
Reducing Harm, Supporting Recovery 2017 – 2025
Ireland’s “Reducing Harm, Supporting Recovery” strategy sets out the Government’s response to addressing the harm caused by substance misuse in our society over the next eight years. It identifies a set of key actions to be delivered between 2017 and 2020, and provides an opportunity for the development of further actions from 2021 to 2024 to address needs that may emerge later on in the lifetime of the strategy (DoH, Ireland)
The drugs situation in Ireland: an overview of trends from 2005 to 2015 (PDF)
This overview analyses ten years of data up to the most recent available with respect to the five European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) key indicators (prevalence of drug use, high risk drug use, treatment demand, drug-related deaths and mortality and drug-related infectious diseases) as well as drug-related crime and supply (Centre for Public Health at Liverpool John Moores University)
2017 Drug Strategy (PDF)
This Strategy sets out clear expectations for action from a wide range of partners, including those in education, health, safeguarding, criminal justice, housing and employment (Home Office)
EMCDDA–Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide (furanylfentanyl)
The two organisations launched a data collection on this substance for the preparation of a Joint Report as stipulated by Article 5.1 of the Council Decision. The Joint Report was submitted to the Council, the Commission and the European Medicines Agency on 23 January 2017. Download
EMCDDA assessment of drug-induced death data and contextual information in selected countries
This report examines the triggers and dynamics of drug-related death in the seven EMCDDA Member States with the highest drug-related death (DRD) rates per population
Chickens coming home to roost: local government public health budgets for 2017/18
The Department for Communities and Local Government has released new data on local authorities’ planned budgets for public health in 2017/18. It does not make good reading (King’s Fund)
A Performance Measurement Framework for Drug and Alcohol Task Forces (PDF)
The development of a Performance Measurement Framework for DATFs follows the review undertaken by the Department of Health in 20121 and adopts a similar logic to the Healthy Ireland strategy. Rather than looking at interventions in terms of inputs and outputs, the overriding concern is with the net effect of public policies at the population level. This is the only way of conceptualising effectiveness in an evidence-based and sustainable manner (Drugs and Alcohol Ireland)
Fentanyl – A Briefing Guide for First Responders (PDF)
Due to the high potency and availability of fentanyl, both transnational and domestic criminal organizations are increasingly utilizing these dangerous synthetic opioids as an adulterant in heroin and other controlled substances. The presence of these synthetic opioids in the illicit U.S. drug market is extremely concerning as the potency of these drugs has led to a significant increase in overdose incidents and overdose‐related deaths throughout the nation (DEA)
Mental health in prisons
Improving the mental health of those in prison will require a step change in effort and resources (National Audit Office)
Illicit Drug Data Report
Our Illicit Drug Data Report (IDDR) informs Australia’s understanding of the illicit drug threat (ACIC)
Alcohol and other drug treatment services in Australia 2015–16
In 2015–16, about 796 alcohol and other drug treatment services provided just over 206,600 treatment episodes to an estimated 134,000 clients (AIHW)
Project Inform releases new report on safer consumption spaces in the U.S
The time is right to unite for a national movement – download (Project Inform)
Public expenditure on supply reduction policies
This report takes a first step towards a systematic analysis, by examining a set of representative attempts to estimate public expenditure on supply reduction interventions (EMCDDA)
Public expenditure on supply reduction policies
Although it is mainly confined to supply reduction expenditures, in order to set the context, it describes the proportion that total drug-related expenditure represents of national public spending and; presents the balance between demand and supply reduction spending for a number of European countries (EMCDDA)
Older People with Drug Problems in Scotland: (PDF)
A Mixed Methods Study Exploring Health and Social Support Needs (Scottish Drugs Forum)
Public expenditure on supply reduction policies
Evaluating drug policy is an integral part of a cost-efficient approach to tackle illicit drugs. This report takes a first step towards a systematic analysis, by examining a set of representative attempts to estimate public expenditure on supply reduction interventions (Health Research Board, Ireland)
The Right Turn Veteran-Specific Recovery Service Evaluation (PDF)
Each year roughly 17,000 people leave the UK Armed Forces and the vast majority make a successful transition into civilian society. A small but increasing number of ex-forces personnel however experience poor physical and mental health, substance misuse and/or come into contact with the criminal justice sector. Poor transition is estimated to have cost the UK £98 million in 2015 alone (Sheffield Hallam University)
Police diversion for cannabis offences: Assessing outcomes and cost-effectiveness
This study compared the cost-effectiveness and outcomes of three kinds of diversions—cautions, expiation and warnings—with the traditional criminal justice system response of charging the offender (AIC)
National Drug Strategy Household Survey (NDSHS) 2016 key findings
The National Drug Strategy Household Survey (NDSHS) collects information on alcohol and tobacco consumption, and illicit drug use among the general population in Australia. It also surveys people’s attitudes and perceptions relating to tobacco, alcohol and other drug use. Survey findings relate mainly to people aged 14 years or older (AIHW)
World Drug Report 2017
To celebrate 20 years since its inception, the World Drug Report 2017 is presented in a new five-booklet format designed to improve reader friendliness while maintaining the wealth of information contained within (UNODC)
Patient Characteristics of Opioid-Related Inpatient Stays and Emergency Department Visits Nationally and by State, 2014 (PDF)
Between 2005 and 2014 there was a dramatic increase nationally in hospitalizations involving opioids: the rate of opioid-related inpatient stays increased 64 percent, and the rate of opioidrelated emergency department (ED) visits nearly doubled (HCUP)
Methiopropamine: a review of the evidence of use and harm
A review of the evidence of use and harm of Methiopropamine (MPA) by the Advisory Council on the Misuse of Drugs (ACMD)
General Report of Activities 2016 – Key achievements and governance: a year in review
The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme. The report is a useful information source for all those seeking comprehensive information on the Centre and its work (EMCDDA)
Precursor chemical import and export authorisation wallchart
This chart outlines the authorisation requirements for importing chemicals into the UK and the requirements for exporting them to different countries across the world (Home Office)
Evidence-based interventions for managing illicit drug dependence
Medical professionals have a key role to play in managing the harms (see Box 1) associated with illicit drug dependence (BMA)
An Overview of the Nation’s Behavioral Health
The Barometer is a unique compilation of facts and figures on issues such as substance use, serious mental illness, serious thoughts of suicide, and related treatment. The findings are broken down into major groups according to age, gender, racial and ethnic categories, income, and access to health insurance (SAMHSA)
- « Previous Page
- 1
- …
- 25
- 26
- 27
- 28
- 29
- …
- 49
- Next Page »
